Cannabis stocks fell after a three-day rally, leaving the index down 25.9% in November. 20% of the 56 stocks tracked here rose in price, with 3 double-digit percentage gainers and 4 double-digit percentage losers. The percentage of stocks with volume above the 30-day average was 5%, up from the 2% in the prior session, with two stocks trading over $5mm in value. Three of the ten highest dollar-volume stocks rose in price as eight traded above $1mm. The 420 Investor Cannabis Stock Index decreased from 64.93 to 62.62, reflecting a change of +59.5% year-to-date in 2016. The index began 2013 at 100, 2014 at 159.1, 2015 at 130.7, and 2016 at 39.25.
This table includes MQTRF, which is an unsponsored ADR, as well as dual-listed tickers ACBFF, AGSTF, APHQF, ATTBF, BLOZF, GWPH, MRPHF, OGRMF, SPRWF, THCBF and TWMJF, and thus is not reflective of all the trading activity in those tickers.
Stocks moving more than 5% on more than $500k in volume included Pharmacyte Biotech (PMCB) and Axim Biotechnologies (AXIM) to the upside and American Cannabis Company (AMMJ), United Cannabis (CNAB), Cannabis Science (CBIS), and Marijuana Company of America (MCOA) to the downside.
Press Releases:
The Daily Dab is brought to you by 420 Investor, a large community of investors seeking to capitalize on cannabis. For just a little over a dollar a day on an annual subscription ($420, or $42 per month), you can get all of the benefits of being a part of 420 Investor, including analysis, alerts, trade recommendations, chat, forums and video updates. Want a quick way to stay on top of the sector? The monthly 420 Investor Newsletter will keep you informed for just $149 per year. Find out why 420 Investors are addicted to the service. To learn more about the sector, download your free guide.
Check us out on Facebook too!
Comments